What regulation, when man is vile?

Last week, Margaret Hamburg, commissioner of the United States Food and Drug Administration (FDA), delivered a tough message to the Indian pharmaceutical sector. Inspections carried out by the FDA of drug manufacturing plants in India had allegedly uncovered major quality issues, triggering this step.

Read Full Story>>